SCHEMBL85832

SCHEMBL85832

CC(C)c1nc2ccccc2[nH]1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.66
POLB P06746 2/20 0.66
IDO1 P14902 1/20 0.66
MLKL Q8NB16 3/20 0.65
HSD17B10 Q99714 3/20 0.65
KDM4E B2RXH2 2/20 0.65
LMNA P02545 1/20 0.65
TAAR1 Q96RJ0 1/20 0.62
HPGD P15428 1/20 0.58
ALOX12 P18054 1/20 0.54
KMT2A Q03164 1/20 0.54
NPC1 O15118 1/20 0.54
ABCB11 O95342 1/20 0.54
TP53 P04637 1/20 0.54
PKM P14618 1/20 0.54
RAB9A P51151 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
ALPL P05186 1/20 0.53
MAPK1 P28482 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30665026 1.00 ALDH1A1 (0.66) ALDH1A1POLBIDO1MLKLHSD17B10
SCHEMBL2147079 0.88 ALDH1A1 (0.66) ALDH1A1POLBIDO1MLKLHSD17B10
SCHEMBL524001 0.84 TAAR1 (0.68) ALDH1A1POLBIDO1MLKLHSD17B10
SCHEMBL21180833 0.84 POLB (0.61) ALDH1A1POLBIDO1MLKLHSD17B10
SCHEMBL1048060 0.84 POLB (0.61) ALDH1A1POLBIDO1MLKLHSD17B10
SCHEMBL23181664 0.84 POLB (0.61) ALDH1A1POLBIDO1MLKLHSD17B10
SCHEMBL8330903 0.84 TAAR1 (0.68) ALDH1A1POLBIDO1MLKLHSD17B10
SCHEMBL22761575 0.84 POLB (0.61) ALDH1A1POLBIDO1MLKLHSD17B10
SCHEMBL2674618 0.84 IDO1 (0.72) ALDH1A1POLBIDO1MLKLLMNA
SCHEMBL9675207 0.84 POLB (0.72) ALDH1A1POLBIDO1MLKLHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115282782-B Total heat exchange membrane doped with functionalized ZIF-7 nanoparticles and preparation method thereof 浙江工业大学 2025-01-28 CN claimed
CN-117683240-A Method for preparing iron-based MOFs by electron beam irradiation, iron-based MOFs and application 上海大学 2024-03-12 CN claimed
CN-116565231-A Preparation method and application of Tian Jing micron-sized selenium or zinc cobalt sulfide composite sheet electrode 太原理工大学 2023-08-08 CN claimed
CN-114752362-A Nano-fluid type wide-temperature-zone heat conduction oil based on ionic liquid and preparation method 四川大学 2022-07-15 CN claimed
CN-114437672-A Ultra-high temperature heat conduction oil based on non-proton type ionic liquid and preparation method thereof 四川大学 2022-05-06 CN claimed
CN-110904473-A 5G antenna environment-friendly copper plating process 中山美力特环保科技有限公司 2020-03-24 CN claimed
WO-2017160361-A1 POLYISOCYANURATE CATALYSTS FOR METAL PANELS AND SPRAY FOAMS HUNTSMAN PETROCHEMICAL LLC (US) 2017-09-21 WO claimed
CN-1891393-A Preflux composition BAIK YANG CHEMICAL CO LTD (KR) 2007-01-10 CN claimed
EP-0428260-B1 Metal surface treatment agents SANWA LAB LTD (JP) 2000-01-05 EP claimed
EP-0562187-B1 Process for production of copper through-hole printed wiring boards SANWA LAB LTD (JP) 1996-01-10 EP claimed
US-5275694-A Printed circuits with copper through holes, negative patterns, photoresists, lamination, dipping and etching SANWA LABORATORY LTD. (JP) 1994-01-04 US claimed
EP-0562187-A1 Process for production of copper through-hole printed wiring boards SANWA LABORATORY LTD. (JP) 1993-09-29 EP claimed
EP-0428260-A2 Metal surface treatment agents SANWA LABORATORY LTD. (JP) 1991-05-22 EP claimed
US-12528797-B2 Heterocyclic compounds for medical treatment C4 THERAPEUTICS, INC. 2026-01-20 US disclosed
WO-2024151833-A1 SPIRO DERIVATIVES AS M4 ACTIVATORS/MODULATORS AND USES THEREOF CEREVEL THERAPEUTICS, LLC (US) 2024-07-18 WO disclosed
US-20240226106-A1 INHIBITORS OF PLASMA KALLIKREIN SHIRE HUMAN GENETIC THERAPIES (US) 2024-07-11 US disclosed
WO-1991013952-A1 IMPROVED MULTIFUNCTIONAL VISCOSITY INDEX IMPROVER-DISPERSANT ANTIOXIDANT (PT-789) EXXON CHEMICAL PATENTS INC. (US) 1991-09-19 WO disclosed
WO-1991013954-A1 NOVEL HETEROCYCLIC NITROGEN COMPOUND MANNICH BASE DERIVATIVES OF AMINO-SUBSTITUTED POLYMERS FOR OLEAGINOUS COMPOSITIONS EXXON CHEMICAL PATENTS INC. (US) 1991-09-19 WO disclosed
EP-0428260-A2 Metal surface treatment agents SANWA LABORATORY LTD. (JP) 1991-05-22 EP disclosed
EP-0400835-A1 Substituted benzimidazoles as angiotensin II antagonists MERCK & CO. INC. (US) 1990-12-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12528797-B2 Heterocyclic compounds for medical treatment CRBN, CUL2, ADRM1 ALDH1A1 2849/4885POLB 2914/4885IDO1 3595/4885
US-20240226106-A1 INHIBITORS OF PLASMA KALLIKREIN KLKB1, KLK5, KLK1 ALDH1A1 3041/4885POLB 4699/4885IDO1 1503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.